comparemela.com
Home
Live Updates
Innovent Releases Results of a Phase 3 Clinical Study of Taf
Innovent Releases Results of a Phase 3 Clinical Study of Taf
Innovent Releases Results of a Phase 3 Clinical Study of Tafolecimab（IBI306）in Chinese Patients with non- Familial Hypercholesterolemia at the American Heart Association (AHA) Scirntific Sessions 2022
/PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes...
Related Keywords
China ,
Taiwan ,
United States ,
Peking ,
Beijing ,
Hong Kong ,
Macau ,
Suzhou ,
Jiangsu ,
Chinese ,
American ,
Innovent Biologics ,
Adimab Incyte ,
Yong Huo ,
Eli Lilly ,
American Cardiology Association Annual Congress ,
American Heart Association ,
Prnewswire Innovent Biologics Inc ,
China Cardiovascular Health ,
Md Anderson Cancer Center ,
China National Medical Products Administration ,
University First Hospital ,
Incyte Corporation ,
Scientific Sessions ,
National Medical Products Administration ,
New Drug Application ,
Peking University First Hospital ,
Lei Qian ,
Vice President ,
Cardiovascular Health ,
Disease Report ,
Three Pivotal Clinical Studies ,
Scientific Session ,
Main Board ,
Stock Exchange ,
Hong Kong Limited ,
Cancer Center ,
Mainland China ,